Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion. (5th January 2022)

Record Type:
Journal Article
Title:
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion. (5th January 2022)
Main Title:
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
Authors:
Gaule, Marina
Pesoni, Camilla
Quinzii, Alberto
Zecchetto, Camilla
Casalino, Simona
Merz, Valeria
Contarelli, Serena
Pietrobono, Silvia
Vissio, Elena
Molinaro, Luca
Manzin, Enrica
Volpatto, Roberta
Vellani, Giorgio
Melisi, Davide
Abstract:
Is Part Of:
JCO precision oncology. Volume 6(2022)
Journal:
JCO precision oncology
Issue:
Volume 6(2022)
Issue Display:
Volume 6, Issue 2022 (2022)
Year:
2022
Volume:
6
Issue:
2022
Issue Sort Value:
2022-0006-2022-0000
Page Start:
Page End:
Publication Date:
2022-01-05
Subjects:
Precision Medicine
Neoplasms
Pharmacogenetics
Molecular Targeted Therapy
Personalized medicine
Oncology
Pharmacogenomics
Periodical
Periodicals
616.994
Journal URLs:
http://po.jco.org ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1200/PO.21.00400 ↗
Languages:
English
ISSNs:
2473-4284
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
22810.xml